TrovaGene, Inc. Warrant
TROVW
TROVW was delisted on the 30th of May, 2017.
4 hedge funds and large institutions have $2.06M invested in TrovaGene, Inc. Warrant in 2016 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and closing their positions.
34% more capital invested
Capital invested by funds: $1.54M → $2.06M (+$520K)
33% more funds holding
Funds holding: 3 → 4 (+1)
12% less call options, than puts
Call options by funds: $93K | Put options by funds: $106K
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
+$525 |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$324 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$34.3K |
| 2 |
Morgan Stanley
New York
|
-$4.7K |
TROVW Hedge Fund Activity: Q1 2016 in Review
4 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in TrovaGene, Inc. Warrant (TROVW) for Q1 2016, worth a combined $2.06M — up 34% from $1.54M a quarter earlier.
Buyers outnumbered sellers: 1 fund opened new TROVW positions and 0 closed out — a net gain of 1 holder — while 1 added to existing stakes and 2 trimmed.
The largest buyer was Tower Research Capital (TRC), adding an estimated $525. The largest seller was Millennium Management, cutting an estimated $34.3K.
- 4 institutional investors held TrovaGene, Inc. Warrant (TROVW) as of Q1 2016, up from 3 in Q4 2015.
- Funds reported $2.06M of TrovaGene, Inc. Warrant stock for Q1 2016, up 34% quarter-over-quarter.
- 1 fund opened new TrovaGene, Inc. Warrant positions in Q1 2016 and 0 closed out, a net change of +1 holder.
- The largest TrovaGene, Inc. Warrant buyer in Q1 2016 was Tower Research Capital (TRC), an estimated $525 added.
- The largest TrovaGene, Inc. Warrant seller in Q1 2016 was Millennium Management, an estimated $34.3K sold.
Based on aggregated 13F filings for Q1 2016.